Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Garcia-Valladares

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Immunotherapy|July 20, 2010
Regulatory T-cell function in autoimmunityIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 24, 2010
Psoriasis pathophysiologyIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 24, 2010
Dysregulated humoral immunity in HIV infectionIgnacio Garcia-Valladares, Luis R Espinoza
The Journal of Rheumatology|February 12, 2010
Ezetimibe-induced relapsing polymyositisIgnacio Garcia-Valladares, Luis R Espinoza
Current Rheumatology Reports|September 17, 2010
Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?Ignacio Garcia-Valladares, Luis R Espinoza
The Journal of Rheumatology|October 4, 2011
Subglottic stenosis is a form of limited Wegener's granulomatosisIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 20, 2010
Designing two-in-one antibodiesIgnacio Garcia Valladares, Luis R Espinoza
The Journal of Rheumatology|January 3, 2012
Psoriatic arthritis: radiographic joint repair following etanercept therapyIgnacio Garcia-Valladares, Raquel Cuchacovich, Luis R Espinoza
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Efficacy and safety of febuxostat in patients with hyperuricemia and goutIgnacio Garcia-Valladares, Tahir Khan, Luis R Espinoza
Drug Design, Development and Therapy|January 27, 2011
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumabIgnacio Garcia-Valladares, Raquel Cuchacovich, Luis R Espinoza
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Immunotherapy|July 20, 2010
Regulatory T-cell function in autoimmunityIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 24, 2010
Psoriasis pathophysiologyIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 24, 2010
Dysregulated humoral immunity in HIV infectionIgnacio Garcia-Valladares, Luis R Espinoza
The Journal of Rheumatology|February 12, 2010
Ezetimibe-induced relapsing polymyositisIgnacio Garcia-Valladares, Luis R Espinoza
Current Rheumatology Reports|September 17, 2010
Is rituximab superior to cyclophosphamide for ANCA-associated vasculitis for induction of remission, and with a better safety profile?Ignacio Garcia-Valladares, Luis R Espinoza
The Journal of Rheumatology|October 4, 2011
Subglottic stenosis is a form of limited Wegener's granulomatosisIgnacio Garcia-Valladares, Luis R Espinoza
Immunotherapy|July 20, 2010
Designing two-in-one antibodiesIgnacio Garcia Valladares, Luis R Espinoza
The Journal of Rheumatology|January 3, 2012
Psoriatic arthritis: radiographic joint repair following etanercept therapyIgnacio Garcia-Valladares, Raquel Cuchacovich, Luis R Espinoza
Therapeutic Advances in Musculoskeletal Disease|August 8, 2012
Efficacy and safety of febuxostat in patients with hyperuricemia and goutIgnacio Garcia-Valladares, Tahir Khan, Luis R Espinoza
Drug Design, Development and Therapy|January 27, 2011
Comparative assessment of biologics in treatment of psoriasis: drug design and clinical effectiveness of ustekinumabIgnacio Garcia-Valladares, Raquel Cuchacovich, Luis R Espinoza
Pageof 3